Seven-year follow-up of patients receiving imatinib for the treatment of newly diagnosed chronic myelogenous leukemia by the TARGET system (Q39512570)

From Wikidata
Jump to navigation Jump to search
scientific article published on 10 December 2010
edit
Language Label Description Also known as
English
Seven-year follow-up of patients receiving imatinib for the treatment of newly diagnosed chronic myelogenous leukemia by the TARGET system
scientific article published on 10 December 2010

    Statements

    Seven-year follow-up of patients receiving imatinib for the treatment of newly diagnosed chronic myelogenous leukemia by the TARGET system (English)
    Masahiro Kizaki
    Shinichiro Okamoto
    Taizo Shimomura
    TARGET Investigators

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit